Lung Cancer Clinical Trial
Official title:
Early Detection of Lung Cancer With Low-dose Multislice Computed Tomography (LDCT)- a Screening Program
NCT number | NCT02754388 |
Other study ID # | 201512060RIND |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | February 2016 |
Est. completion date | December 2019 |
Verified date | February 2020 |
Source | National Taiwan University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
Lung cancer is one of the leading causes of cancer-related death in Taiwan. Early diagnosis
of lung cancer may improve cancer survival. Low-dose computed tomography (LDCT) was thought
to be the best screening tool for lung cancer. However, there is growing concerns about
radiation exposure, high cost, and high rate of false-positive screening result.
Epidemiologic studies from western countries showed that cigarette smoking is the major cause
of lung cancer, and other risk factors may include age, environmental pollution, occupational
exposures (included of radon exposure), gender, race, and pre-existing lung diseases.
Adenocarcinoma is the major type of lung cancer in Taiwan and is less attributable to
smoking. The investigators need a different risk prediction model adapted to the
investigators country.
National Taiwan University Hospital Chu-Tung Branch initiated the lung cancer screening by
LDCT since June 2015. Many people can get the LDCT screening with affordable price with the
subsidy from enterprise donation. The purpose of this study is observing those participants
with 2-year follow-up. Furthermore, those data may connect with another study of "Low dose
computed tomography screening study in nonsmoker with risk factors for lung cancer in Taiwan"
(Non-smoker study)which is implemented in other hospitals in Taiwan.For reality limiting,
After one year, the enrollment rate was a lot lower than expected. We extended the enrollment
time but only observe those participants for one year not two year..
Status | Completed |
Enrollment | 1334 |
Est. completion date | December 2019 |
Est. primary completion date | May 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years and older |
Eligibility |
Inclusion Criteria: - age>=20 - self pay the LDCT in National Taiwan University Hospital Chu-Tung Branch - ability to understand the informed consent form for complete the questionnaires - be willing and able to accept telephone access at the time scheduled Exclusion Criteria: NA |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
National Taiwan University Hospital |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Abnormal ct finding detection rate | Abnormal ct finding detection rate is defined as number of abnormal ct finding/total enroll number | 1-month | |
Secondary | Change in Chinese 14-item Perceived Stress Scale (Chinese 14-item PSS) score | Stress will be measured using the Chinese 14-item Perceived Stress Scale (Chinese 14-item PSS) at baseline and 6 month follow-up. | 6-month | |
Secondary | Change in Chinese Health Questionnaire-12 (CHQ-12) score | Psychological morbidity will be measured using the Chinese Health Questionnaire (CHQ-12) at baseline and 12 month follow-up. | 12-month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03918538 -
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
|
N/A | |
Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|